MedTrace Logo

Multicenter Dispensing Study of Biofinity Lenses in Extended Range

NCT02060539 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2017-12-11

Study results available
· View outcomes & findings →

Summary

To obtain subjective and objective feedback on the clinical performance of Biofinity lenses after at least two weeks daily wear in existing contact lens wearers compared with their habitual lenses.

Conditions

  • Myopia
  • Hyperopia

Interventions

DEVICE

Biofinity XR

Sponsors & Collaborators

  • CooperVision, Inc.

    lead INDUSTRY

Principal Investigators

  • Lyndon Jones · CCLR, University of Waterloo

  • Meng Lin · CRC, University of California Berkeley

  • Jan Bergmanson · TERTC, University of Houston

  • Pete Kollbaum · CORL, Indiana University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2014-04-30
Completion
2014-12-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02060539 on ClinicalTrials.gov